Key Events This Week
23 Feb: Shares hit lower circuit amid heavy selling pressure
27 Feb: Stock surged to upper circuit on strong buying interest
Weekly Close: Rs.111.00, down 5.37% vs Sensex -0.96%
23 February 2026: Lower Circuit Hit Amid Heavy Selling Pressure
Lotus Eye Hospital & Institute Ltd’s shares plunged sharply on 23 Feb 2026, hitting the lower circuit limit as intense selling overwhelmed demand. The stock closed at Rs.111.55, down Rs.5.75 or 4.90% on the day, despite the Sensex rising 0.39%. Intraday volatility was pronounced, with the price swinging between an intraday high of Rs.120.35 (+2.42%) and a low of Rs.111.64 (-5.0%). The weighted average price indicated that most trading volume occurred near the day’s low, signalling dominant selling pressure throughout the session.
This decline extended a three-day losing streak, cumulatively erasing over 13% of the stock’s value. The stock traded below its short- and medium-term moving averages, though it remained above the 200-day average, highlighting technical weakness. Delivery volumes also declined, suggesting waning long-term investor participation and possible panic selling. The hospital sector gained 0.65% that day, underscoring Lotus Eye Hospital’s relative underperformance.
24-26 February 2026: Continued Volatility and Mixed Price Movements
On 24 Feb, the stock further declined by 2.64% to Rs.108.60, underperforming the Sensex which fell 0.78%. Trading volumes remained moderate but delivery volumes continued to shrink, reflecting cautious investor sentiment. The stock rebounded slightly on 25 Feb, gaining 0.74% to Rs.109.40, while the Sensex rose 0.41%. However, on 26 Feb, the stock slipped marginally by 0.37% to Rs.109.00 despite the Sensex advancing 0.19%, indicating persistent pressure on the stock amid broader market gains.
Handpicked from 50, scrutinized by experts – Our recent selection, this Mid Cap from Bank - Public, is already delivering results. Don't miss next month's pick!
- - Expert-scrutinized selection
- - Already delivering results
- - Monthly focused approach
27 February 2026: Upper Circuit Surge on Strong Buying Interest
In a dramatic turnaround, Lotus Eye Hospital & Institute Ltd surged to hit the upper circuit limit on 27 Feb 2026, closing at Rs.111.00, up Rs.2.00 or 1.83% from the previous close. The stock touched an intraday high of Rs.113.38, a 4.99% gain, triggering a regulatory freeze on further price movement. This rally contrasted with the Sensex’s 1.16% decline and the hospital sector’s 0.39% fall, highlighting the stock’s relative strength amid a weak market backdrop.
Despite the price surge, delivery volumes remained subdued, with only 8,580 shares delivered on 26 Feb, down 83.58% from the five-day average. The weighted average price suggested that a significant portion of trading occurred near the day’s low, indicating some resistance at higher levels. Technically, the stock remains below its short- and medium-term moving averages but above the 200-day average, signalling cautious optimism among traders.
The stock’s Mojo Score remains at 51.0 with a Hold rating, upgraded from Strong Sell in May 2025, reflecting improved fundamentals but ongoing volatility. The upper circuit hit and unfilled buy orders suggest sustained investor interest, though the micro-cap status and low liquidity continue to pose risks of sharp price swings.
Holding Lotus Eye Hospital & Institute Ltd from ? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!
- - Peer comparison ready
- - Superior options identified
- - Cross market-cap analysis
Daily Price Performance vs Sensex
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-02-23 | Rs.111.55 | -4.90% | 36,817.86 | +0.39% |
| 2026-02-24 | Rs.108.60 | -2.64% | 36,530.09 | -0.78% |
| 2026-02-25 | Rs.109.40 | +0.74% | 36,679.75 | +0.41% |
| 2026-02-26 | Rs.109.00 | -0.37% | 36,748.49 | +0.19% |
| 2026-02-27 | Rs.111.00 | +1.83% | 36,322.56 | -1.16% |
Key Takeaways
The week for Lotus Eye Hospital & Institute Ltd was characterised by significant volatility and a net decline of 5.37%, underperforming the Sensex’s 0.96% fall. The lower circuit hit on 23 Feb reflected intense selling pressure and investor nervousness, exacerbated by declining delivery volumes and technical weakness below key moving averages.
However, the upper circuit surge on 27 Feb demonstrated renewed buying interest and relative strength against a weakening market and sector backdrop. Despite this rebound, delivery volumes remained subdued, indicating that long-term investor conviction has yet to fully return. The stock’s Mojo Score upgrade to Hold signals some fundamental improvement, but the micro-cap nature and low liquidity continue to pose risks of sharp price swings.
Investors should note the stock’s technical positioning: while it remains above the 200-day moving average, it trades below shorter-term averages, suggesting that momentum is still fragile. The regulatory freeze following the upper circuit hit highlights the stock’s susceptibility to sudden moves, requiring careful monitoring of volume and price action in coming sessions.
Conclusion
Lotus Eye Hospital & Institute Ltd’s week was a study in contrasts, with a sharp early-week sell-off followed by a strong late-week rally. The stock’s 5.37% weekly decline, despite outperforming the Sensex’s fall, underscores ongoing volatility and investor caution in this micro-cap healthcare name. The recent Mojo rating upgrade to Hold reflects some stabilisation in fundamentals, yet technical indicators and delivery volume trends counsel prudence.
Market participants should remain alert to further developments, particularly any sustained volume support or breakouts above key moving averages that could signal a more durable recovery. Until then, the stock’s price action is likely to remain choppy, influenced by speculative trading and sector-specific dynamics.
Only Rs. 9,999 - Get MojoOne for 1 Year + 3 Months FREE (60% Off) Start Today
